February 19, 2026 -
MolecuLight Victorious in its Efforts to Prove Adiuvo Diagnostics Private Ltd. Did Not Merit a Patent
Pittsburgh, USA – February 19, 2026 – MolecuLight® Corp., the global leader in real-time detection of elevated bacterial loads in wounds through point-of-care fluorescence imaging, is pleased to announce that India’s
… Read More
February 5, 2026 -
Pittsburgh, USA, February 05, 2026 – MolecuLight today announced that the United States International Trade Commission (“ITC”) has formally instituted an investigation into the SnapshotGLO product, following the complaint previously filed by MolecuLight Corp and MolecuLight Inc. The investigation will examine whether the SnapshotGLO product infringes U.S.
… Read More
January 29, 2026 -
Pittsburgh, USA, January 29, 2026 – MolecuLight today announced that its MolecuLightDX® wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical Device Development Tool (MDDT). The FDA’s MDDT program qualifies select, scientifically validated tools for use in medical device development
… Read More
January 13, 2026 -
Pittsburgh, PA, USA – January 13, 2026 – MolecuLight Corp. and MolecuLight Inc., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria and digital wound measurement, today announced that it has filed a complaint with the United States International Trade Commission (ITC) requesting
… Read More
December 16, 2025 -
Tissue Analytics moves toward a unified, AI-powered imaging experience that seamlessly connects data from point-of-care devices to EHR workflows
PITTSBURGH, PA – Dec. 16, 2025 – Net Health today announced the platform integration of MolecuLight with Tissue Analytics, its AI-powered mobile wound imaging and analytics solution. This enables
… Read More
December 9, 2025 -
Streamlined integration enhances wound care by combining bacterial detection, digital wound measurements, and thermal imaging with direct Oracle Health Foundation EHR connectivity
Pittsburgh, USA, December 9, 2025 – MolecuLight Corp., a global leader in point-of-care fluorescence imaging for wound assessment and an Oracle partner, today announced the
… Read More
November 13, 2025 -
Pittsburgh, USA – November 13, 2025 – MolecuLight Corp., a global leader in point-of-care fluorescence imaging for wound assessment, is proud to announce the publication of a landmark international consensus report, developed by leading experts in wound care and surgery from across the United States. The report,
… Read More
September 4, 2025 -
Pittsburgh, USA – September 4, 2025 – MolecuLight Corp., the global leader in point-of-care fluorescence imaging for wound care, announces continued innovation in wound care technology and its presence at the Symposium on Advanced Wound Care (SAWC) Fall 2025, September 3–6 in Las Vegas, NV. Attendees can
… Read More
August 27, 2025 -
PITTSBURGH, USA and TAIPEI, TAIWAN, August 27, 2025 – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, together with its Taiwanese distributor, Healtdeva Company Ltd., today announced the publication of the largest-ever randomized controlled trial (RCT) on its technology. Independently conducted and published
… Read More 
